These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Thermostability of an inactivated hepatitis A vaccine stored at 37 degrees C for one week. Wiedermann G, Ambrosch F, André FE, Delem A, D'Hondt E, Safary A. J Med Virol; 1994 Dec; 44(4):442. PubMed ID: 7897377 [No Abstract] [Full Text] [Related]
25. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. J Gastroenterol Hepatol; 1993 Dec; 8(4):338-41. PubMed ID: 8397010 [Abstract] [Full Text] [Related]
26. Immunogenicity of inactivated hepatitis A vaccine in children. Lee SD, Lo KJ, Chan CY, Yu MY, Wang YJ, Safary A. Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802 [Abstract] [Full Text] [Related]
27. Hepatitis A vaccine. Bader TF. Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483 [Abstract] [Full Text] [Related]
28. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine. Kurup A, San LM, Yew WS. Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178 [No Abstract] [Full Text] [Related]
29. Antibody response to nonstructural proteins of hepatitis A virus following infection. Robertson BH, Jia XY, Tian H, Margolis HS, Summers DF, Ehrenfeld E. J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561 [Abstract] [Full Text] [Related]
30. Determination of hepatitis A antibody response to vaccination by an enzyme immunoassay. Zuckerman JN, Powell L, Lequin RM, Zuckerman AJ. J Virol Methods; 1996 Jan; 56(1):27-31. PubMed ID: 8690763 [Abstract] [Full Text] [Related]
31. Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine. Binn LN, MacArthy PO, Marchwicki RH, Sjogren MH, Hoke CH, Burge JR, D'Hondt E. Vaccine; 1992 Jan; 10 Suppl 1():S102-5. PubMed ID: 1335636 [Abstract] [Full Text] [Related]
33. Field evaluation of a hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon. Aarhaug P. Vaccine; 1992 Jan; 10 Suppl 1():S156-8. PubMed ID: 1335651 [Abstract] [Full Text] [Related]
35. Persistence of antibodies after inactivated hepatitis A vaccines in a comparative study. Goilav C, Zuckerman J, Lafrenz M, Vidor E, Briantais P, Lauwers S, Ratheau C, Benichou G, Zuckerman A. J Infect; 1997 Mar; 34(2):158. PubMed ID: 9138144 [No Abstract] [Full Text] [Related]
36. Inactivated hepatitis A virus vaccines. Lemon SM. Hepatology; 1992 Jun; 15(6):1194-7. PubMed ID: 1317341 [No Abstract] [Full Text] [Related]
37. Production, quality control and characterization of an inactivated hepatitis A vaccine. Peetermans J. Vaccine; 1992 Jun; 10 Suppl 1():S99-101. PubMed ID: 1335671 [Abstract] [Full Text] [Related]
39. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Reuman PD, Kubilis P, Hurni W, Brown L, Nalin D. Vaccine; 1997 Jul; 15(10):1157-61. PubMed ID: 9269062 [Abstract] [Full Text] [Related]
40. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. Sjogren MH, Purcell RH, McKee K, Binn L, Macarthy P, Ticehurst J, Feinstone S, Caudill J, See A, Hoke C. Vaccine; 1992 Jul; 10 Suppl 1():S135-7. PubMed ID: 1335645 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]